Humira biosimilars are expected to reduce annual pharmaceutical expenditures by $5 billion, but they may be delayed by rebate strategies.
from Section Page News - Modern Healthcare https://ift.tt/oQNBDd0
Showing posts with label Rebate walls may thwart biosimilar savingsSection Page News - Modern Healthcare. Show all posts
Showing posts with label Rebate walls may thwart biosimilar savingsSection Page News - Modern Healthcare. Show all posts
Tuesday, September 13, 2022
Rebate walls may thwart biosimilar savingsRebate walls may thwart biosimilar savingsRebate walls may thwart biosimilar savings
Rebate walls may thwart biosimilar savings
from Section Page News - Modern Healthcare https://ift.tt/oQNBDd0
from Section Page News - Modern Healthcare https://ift.tt/oQNBDd0
Subscribe to:
Posts (Atom)